Latest / Breastcancer.org Podcast
Teaching the Immune System to Fight Cancer
Antibody-drug conjugates (ADCs) are a relatively new type of medicine for breast cancer. Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) and Dato-DXd (brand name: Datroway) are two ADCs used to treat breast cancer.
Dr Benjamin Schrank and colleagues have developed a new type of ADC that combines an antibody with a toxin — called an antibody-toxin conjugate — that teaches the immune system to recognize and attack cancer cells.
Listen to the episode to hear Dr. Schrank explain:
the antibody and the toxin component of the medicine
how the new medicine works
possible side effects
next…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.